YM155, also known as Sepantronium bromide, is a potent small-molecule survivin inhibitor utilized primarily in oncology research for its potential as an antineoplastic agent. As a targeted therapy, it… Read more
YM155, also known as Sepantronium bromide, is a potent small-molecule survivin inhibitor utilized primarily in oncology research for its potential as an antineoplastic agent. As a targeted therapy, it functions by suppressing the expression of survivin, an anti-apoptotic protein often upregulated in various cancer types, thereby promoting apoptosis in tumor cells. Laboratories working with this compound require high-quality analytical tools to ensure precision in their studies. This category includes YM155 reference standards and stable isotope labelled analogues, such as the 13C-d3 variant, which are critical for impurity profiling and rigorous quality control. These stable isotope labelled compounds are indispensable for accurate quantification during pharmacokinetic studies and the validation of complex analytical methods, providing reliable benchmarks for researchers investigating survivin-dependent cell death and other therapeutic pathways in clinical and preclinical settings.